Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Validation Process of NMOSDCopilotTM, a Software as a Medical Device (SaMD) for Patients Living with Neuromyelitis Optica Spectrum Disorder

Author:Levy, Michael   Sotirchos, Elias   Carment, Loic   Gorin, Clarissa   Klaeyle, Lissandra   Ravindra, Dellini   Touré Cuq, Emma   Vivès, Alizé   Fam, Sami   Kielhorn, Adrian   Aras, Emrah   Zinaï, Saad   De Seze, Jerome   

Session Name:P10: Autoimmune Neurology: NMOSD  

Topic:Autoimmune Neurology  

Program Number:P10.001  

Author Institution:Massachusetts General Hospital/Harvard Medical School, Boston, USA, Boston, MA  Johns Hopkins University, Baltimore, USA, Baltimore, MD  Ad Scientiam, Paris, France, Paris, France  Alexion, AstraZeneca Rare Disease, Boston, MA, Wayland, MA  Hôpital Civil, Strasbourg University, Strasbourg, France, Strasbourg, France  

Indirect Treatment Comparison of Ravulizumab Versus Approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-Positive (AQP4-IgG+) Neuromyelitis Optica Spectrum Disorder (NMOSD)

Author:Clardy, Stacey   Pittock, Sean   Aktas, Orhan   Nakahara, Jin   Isobe, Noriko   Centonze, Diego   Fam, Sami   Kielhorn, Adrian   Yu, Jeffrey   Jansen, Jeroen   Zhang, Ina   

Session Name:P10: Autoimmune Neurology: NMOSD  

Topic:Autoimmune Neurology  

Program Number:P10.005  

Author Institution:University of Utah, Salt Lake City, UT  Mayo Clinic, Rochester, MN  Heinrich Heine University, Düsseldorf, Germany  Keio University, Tokyo, Japan  Kyushu University, Fukuoka, Japan  Tor Vergata University, Rome, Italy  Alexion, AstraZeneca Rare Disease, Boston, MA  PRECISIONheor, San Francisco, CA